Today, China's National Medical Product Administration (NMPA) announced the extension of the deadline for high-risk class III devices until January 1, 2021. The original deadline would've been on October 1, 2020. The NMPA announced the change at short notice.
New partnerships and future strategy in the healthcare sector
At atrify, we always strive to offer our customers the best possible solutions. After the...